Table 5.
Therapeutic Target | Liver Enzyme Abnormality | Lipids/Creatine Kinase |
---|---|---|
TNF | Continue: if <2x ULN Stop: >2x ULN or (+) Hepatitis B or autoimmune hepatitis |
Continue |
Integrin | Continue, but monitor | Continue |
IL 12/23 | Continue | Continue |
JAK | Continue | Continue, but monitor |
IL: interleukin; JAK: Janus kinase; ULN: upper limit of normal